Positive tuberculin skin test or interferon-gamma release assay in patients with radiographic lesions suggesting old healed tuberculosis

Journal of Korean Medical Science

Volumn 27, Issue 7, 2012, Pages 761-766

  Jeong, Yun Jeong ^a   Yoon, Soonho ^a   Koo, Hyeon kyoung ^a   Lim, Hyo Jeong ^a,b   Lee, Ji Sun ^a   Lee, Sang Min ^a   Yang, Seok Chul ^a   Yoo, Chul Gyu ^a   Kim, Young Whan ^a   Han, Sung Koo ^a   Yim, Jae Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Pulmonary; Radiology and other imaging; Tuberculosis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; INTERFERON GAMMA RELEASE ASSAY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84866509794     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2012.27.7.761     Document Type: Article

References (33)

1. World Health Organization. Global tuberculosis control: WHO report 2010. Geneva: World Health Organization, 2010.
2. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-7.
3. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26: 28-106.
4. International Union Against Tuberculosis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 1982; 60: 555-64.
5. Linh NN, Marks GB, Crawford AB. Radiographic predictors of subsequent reactivation of tuberculosis. Int J Tuberc Lung Dis 2007; 11: 1136-42.
6. Schluger NW, Burzynski J. Recent advances in testing for latent TB. Chest 2010; 138: 1456-63.
7. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161: S221-47.
8. Cellestis. QuantiFERON®-TB Gold In-Tube Package Insert. 2006.
9. Sokal JE. Editorial: Measurement of delayed skin-test responses. N Engl J Med 1975; 293: 501-2.
10. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000; 49: 1-51.
11. Fleiss JL, Levin B, Paik M. The measurement of interrater agreement. In: Shewart WA, editor. Statistical methods for rates and proportions. 3rd ed. Hoboken, NJ: John Wiley & Sons, 2004, p 598-626.
12. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27: 442-8.
13. Matulis G, Jüni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008; 67: 84-90.
14. Seyhan EC, Sökücü S, Altin S, Günlüoglu G, Trablus S, Yilmaz D, Koksalan OK, Issever H. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 2010; 12: 98-105.
15. Joshi R, Patil S, Kalantri S, Schwartzman K, Menzies D, Pai M. Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response. PLoS One 2007; 2: e805.
16. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012; 67: 62-70.
17. Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, Cobelens FG, van Houte AJ, Bossink AW. Comparison of two interferongamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618-27.
18. Perez-Stable EJ, Flaherty D, Schecter G, Slutkin G, Hopewell PC. Conversion and reversion of tuberculin reactions in nursing home residents. Am Rev Respir Dis 1988; 137: 801-4.
19. Woodruff CE, Chapman PT. Tuberculin sensitivity in elderly patients. Am Rev Respir Dis 1971; 104: 261-3.
20. Schablon A, Harling M, Diel R, Nienhaus A. Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis 2010; 10: 107.
21. Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TBGold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest 2009; 135: 1010-8.
22. Lee SW, Lee CT, Yim JJ. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis 2010; 10: 300.
23. Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, Oka M. Longterm follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med 2008; 47: 1957-61.
24. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37: 88-99.
25. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007; 30: 945-50.
26. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection: analysis of discordant results, when compared to the tuberculin skin test. PLoS One 2008; 3: e2665.
27. Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010; 10: 57.
28. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137: 952-68.
29. Malaviya AN, Kapoor S, Garg S, Rawat R, Shankar S, Nagpal S, Khanna D, Furst DE. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India: an audit report. J Rheumatol 2009; 36: 1414-20.
30. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1952-6.
31. Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, Barde C, Marazza G, Panizzon RG, Saurat JH. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol 2009; 161: 797-800.
32. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, Noma S. Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy. Radiology 1993; 186: 653-60.
33. Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009; 136: 198-204.